GSK GlaxoSmithKline PLC ADRs

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:GSK.

$39.01  +0.29 (0.75%)
As of 10/15/2021 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  09/04/2001
Outstanding shares:  2,515,538,097
Average volume:  4,206,073
Market cap:   $97,401,635,116
Current dividend yield:  5.56%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    37733W105
ISIN:        US37733W1053
Sedol:      2374112
Valuation   (See tab for details)
PE ratio:   16.31
PB ratio:   6.35
PS ratio:   2.17
Return on equity:   20.34%
Net income %:   13.34%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy